Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-26 @ 3:51 AM
Study NCT ID:
NCT02885818
Status:
COMPLETED
Last Update Posted:
2019-04-19
First Post:
2016-08-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
Sponsor:
University Hospital, Brest
Organization:
Study Overview
Official Title:
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ABATACEPT_B
Brief Summary:
Abatacept disrupts T-cell coactivation signals in rheumatoid arthritis (RA). Its potential effects on B cells are not well described. This study will assess the effects of abatacept therapy on the phenotype and function of peripheral blood B cells in patients with RA.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: